Delivery Order SPE2DB22D3004-SPE2DB25FPD39

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,166.24 issued by the Defense Logistics Agency (DLA) for 4,566,963,078 units of Vancomycin HCL 2 gram vials. The order has a firm fixed price and a completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.84, is for the delivery of 4,567,389,320 vials of vancomycin hydrochloride, a critical antibiotic medication. The contract has a completion date of February 27, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $3,398.67 for the supply of 4,566,429,815 units of Vancomycin HCL 2 gram vials. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 14, 2024 with a completion date of November 15, 2024. This Delivery Order is placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,466.70 firm fixed-price delivery order is for the supply of 4,566,869,853 units of Vancomycin HCl 2 gram vials. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,361.82 firm fixed-price delivery order is for the supply of 4,566,555,560 vials of the antibiotic Vancomycin 1 gram. The contract has a completion date of November 27, 2024 and was awarded on November 26, 2022. No set-aside designation was used for this competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,074.88 firm fixed-price delivery order is for the supply of 4,566,565,156 units of Vancomycin HCl 1.75 gram vials. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM7S8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $1,433.60, is for the supply of 4567314814 - VANCOMYCIN HCL 750 MG VIALS. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,030,221 units of Vancomycin HCL 1GM over a contract period ending on February 21, 2025. The award is a Firm Fixed Price Delivery Order with a ceiling value of $1,777.98. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,725.74 firm fixed-price contract is for the supply of Vancomycin HCL 1.25 gram vials, a critical antibiotic medication. The contract has a period of performance through February 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,034.25 Firm Fixed Price delivery order is for the supply of 4567291023 - VANCOMYCIN 1.5 GRAM/300 ML BAG 300ML, with a period of performance through February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPD39
    Delivery Order

This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPD39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,189.75 firm fixed-price delivery order is for the supply of 4,566,961,726 vials of Vancomycin HCl 1.75 gram. The contract has an ultimate completion date of January 17, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/21/25, 10:29 AM